/Companies

Epion Therapeutics</a> (Copy)

2 known investors

Find your way into Epion Therapeutics</a> (Copy)

Sign up to see every warm intro you have to Epion Therapeutics</a> (Copy)

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Epion Therapeutics</a> (Copy) team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.

Founders & leadership

MDMichael D. Webb
Michael D. WebbPresident & CEO, Board Member
EPEdward Parsons
Edward ParsonsChief Operating Officer
MWMichael W. Belin
Michael W. BelinChief Medical Officer

Investors · 2

Frequently asked questions

What does Epion Therapeutics</a> (Copy) do?
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
Who are Epion Therapeutics</a> (Copy)'s investors?
Epion Therapeutics</a> (Copy)'s investors include 7G BioVentures, New World Angels.